Classification of stillbirths and risk factors by cause of death - A case-control study

Acta Obstetricia et Gynecologica Scandinavica

Volumn 92, Issue 3, 2013, Pages 325-333

  Helgadõttir, Linda Björk ^a,b   Turowski, Gitta ^a,b   Skjeldestad, Finn Egil ^c   Jacobsen, Anne Flem ^a   Sandset, Per Morten ^b   Roald, Borghild ^a,b   Jacobsen, Eva Marie ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Classification; fetal death; risk factor; stillbirth; thrombophilia

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CAUSE OF DEATH; CLASSIFICATION; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; GENETIC POLYMORPHISM; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICAL INFORMATICS; PLACENTA; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMALL FOR DATE INFANT; SMOKING; STILLBIRTH; THROMBOEMBOLISM; VALIDATION STUDY;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; BIRTH WEIGHT; CASE-CONTROL STUDIES; CAUSE OF DEATH; DIABETES, GESTATIONAL; FEMALE; FETAL DEATH; GESTATIONAL AGE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; NORWAY; ODDS RATIO; PLACENTA DISEASES; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY, TWIN; PREVALENCE; PROTHROMBIN; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; STILLBIRTH; THROMBOPHILIA;

EID: 84874422607     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.12044     Document Type: Article

References (32)

1. Flenady V, Middleton P, Smith GC, Duke W, Erwich JJ, Khong TY, et al. Stillbirths: the way forward in high-income countries. Lancet. 2011; 377: 1703-17.
2. Smith GC, Fretts RC,. Stillbirth. Lancet. 2007; 370: 1715-25.
3. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol. 2006; 132: 171-96.
4. Froen JF, Pinar H, Flenady V, Bahrin S, Charles A, Chauke L, et al. Causes of death and associated conditions (CODAC): a utilitarian approach to the classification of perinatal deaths. BMC Pregnancy Childbirth. 2009; 9: 22.
5. Jacobsen AF, Skjeldestad FE, Sandset PM,. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study. J Thromb Haemost. 2008; 6: 905-12.
6. Helgadottir LB, Skjeldestad FE, Jacobsen AF, Sandset PM, Jacobsen EM,. Incidence and risk factors of fetal death in Norway: a case-control study. Acta Obstet Gynecol Scand. 2011; 90: 390-7.
7. Helgadottir LB, Skjeldestad FE, Jacobsen AF, Sandset PM, Jacobsen EM,. The association of intrauterine fetal death and inherited thrombophilia-a case-control study. Blood Coagul Fibrinolysis. 2011; 22: 651-6.
8. Helgadottir LB, Skjeldestad FE, Jacobsen AF, Sandset PM, Jacobsen EM,. The association of antiphospholipid antibodies with intrauterine fetal death: a case-control study. Thromb Res. 2012; 130: 32-7.
9. Skjaerven R, Gjessing HK, Bakketeig LS,. Birthweight by gestational age in Norway. Acta Obstet Gynecol Scand. 2000; 79: 440-9.
10. Bergrem A, Jacobsen EM, Skjeldestad FE, Jacobsen AF, Skogstad M, Sandset PM,. The association of antiphospholipid antibodies with pregnancy-related first time venous thrombosis-a population-based case-control study. Thromb Res. 2010; 125: e222-7.
11. Jacobsen EM, Barna-Cler L, Taylor JM, Triplett DA, Wisloff F,. The Lupus Ratio test-an interlaboratory study on the detection of Lupus anticoagulants by an APTT-based, integrated, and semi-quantitative test. Fifth International Survey of Lupus Anticoagulants-ISLA 5. Thromb Haemost. 2000; 83: 704-8.
12. Korteweg FJ, Erwich JJ, Folkeringa N, Timmer A, Veeger NJ, Ravise JM, et al. Prevalence of parental thrombophilic defects after fetal death and relation to cause. Obstet Gynecol. 2010; 116: 355-64.
13. Goldenberg RL, McClure EM, Saleem S, Reddy UM,. Infection-related stillbirths. Lancet. 2010; 375: 1482-90.
14. Flenady V, Froen JF, Pinar H, Torabi R, Saastad E, Guyon G, et al. An evaluation of classification systems for stillbirth. BMC Pregnancy Childbirth. 2009; 9: 24.
15. Gardosi J, Kady SM, McGeown P, Francis A, Tonks A,. Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study. Br Med J. 2005; 331: 1113-17.
16. Korteweg FJ, Gordijn SJ, Timmer A, Holm JP, Ravise JM, Erwich JJ,. A placental cause of intra-uterine fetal death depends on the perinatal mortality classification system used. Placenta. 2008; 29: 71-80.
17. CESDI-Confidental enquiry into Stillbirths and Deaths in infancy. 8th Annual Report. 2001.
18. Korteweg FJ, Gordijn SJ, Timmer A, Erwich JJ, Bergman KA, Bouman K, et al. The Tulip classification of perinatal mortality: introduction and multidisciplinary inter-rater agreement. Br J Obstet Gynaecol. 2006; 113: 393-401.
19. de Galan-Roosen AE, Kuijpers JC, van der Straaten PJ, Merkus JM,. Evaluation of 239 cases of perinatal death using a fundamental classification system. Eur J Obst Gynecol Reprod Biol. 2002; 103: 37-42.
20. Rayburn W, Sander C, Barr M Jr, Rygiel R,. The stillborn fetus: placental histologic examination in determining a cause. Obstet Gynecol. 1985; 65: 637-41.
21. Cnattingius S, Stephansson O,. The epidemiology of stillbirth. Semin Perinatol. 2002; 26: 25-30.
22. Wisborg K, Kesmodel U, Henriksen TB, Olsen SF, Secher NJ,. Exposure to tobacco smoke in utero and the risk of stillbirth and death in the first year of life. Am J Epidemiol. 2001; 154: 322-7.
23. Beischer NA, Wein P, Sheedy MT, Steffen B,. Identification and treatment of women with hyperglycaemia diagnosed during pregnancy can significantly reduce perinatal mortality rates. Aust N Z J Obstet Gynaecol. 1996; 36: 239-47.
24. Pinar H, Carpenter M,. Placenta and umbilical cord abnormalities seen with stillbirth. Clin Obstet Gynecol. 2010; 53: 656-72.
25. Goldenberg RL, Kirby R, Culhane JF,. Stillbirth: a review. J Matern-Fetal Neo M. 2004; 16: 79-94.
26. Sibai B, Dekker G, Kupferminc M,. Pre-eclampsia. Lancet. 2005; 365: 785-99.
27. Rodger MA, Betancourt MT, Clark P, Lindqvist PG, Dizon-Townson D, Said J, et al. The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies. PLoS Med. 2010; 7: e1000292.
28. Salafia CM, Minior VK, Pezzullo JC, Popek EJ, Rosenkrantz TS, Vintzileos AM,. Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features. Am J Obstet Gynecol. 1995; 173: 1049-57.
29. Redline RW,. Thrombophilia and placental pathology. Clin Obstet Gynecol. 2006; 49: 885-94.
30. Hafner E, Metzenbauer M, Hofinger D, Stonek F, Schuchter K, Waldhor T, et al. Comparison between three-dimensional placental volume at 12 weeks and uterine artery impedance/notching at 22 weeks in screening for pregnancy-induced hypertension, pre-eclampsia and fetal growth restriction in a low-risk population. Ultrasound Obstet Gynecol. 2006; 27: 652-7.
31. Audibert F, Benchimol Y, Benattar C, Champagne C, Frydman R,. Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry. Fet Diagn Ther. 2005; 20: 48-53.
32. Toal M, Chan C, Fallah S, Alkazaleh F, Chaddha V, Windrim RC, et al. Usefulness of a placental profile in high-risk pregnancies. Am J Obstet Gynecol. 2007; 196: 363-7.